XENON PHARMACEUTICALS INC. (XENE) Total assets 2016–2025
XENON PHARMACEUTICALS INC. (XENE) total assets at each fiscal year-end, per SEC filings.
$633.2MFY2025 · since FY2016: $67.5M → $633.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $633.2M | -20.7% |
| FY2024 | $798.1M | -17.3% |
| FY2023 | $964.8M | +27.9% |
| FY2022 | $754.1M | +31.8% |
| FY2021 | $572.0M | +202.4% |
| FY2020 | $189.2M | +28.1% |
| FY2019 | $147.7M | — |
| FY2017 | $46.1M | -31.7% |
| FY2016 | $67.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XENE financial trends
XENE RevenueXENE Net incomeXENE Net marginXENE Gross profitXENE Gross marginXENE Operating incomeXENE Operating marginXENE Operating cash flowXENE Free cash flowXENE Capital expendituresXENE Return on equityXENE Stock buybacksXENE Dividends paidXENE Total liabilitiesXENE Shareholders’ equityXENE overview →